中国微创外科杂志
中國微創外科雜誌
중국미창외과잡지
CHINESE JOURNAL OF MINIMALLY INVASIVE SURGERY
2014年
8期
711-712,728
,共3页
张国飞%吴越%汪清%邓玮%陈安龙%孙研%闫振
張國飛%吳越%汪清%鄧瑋%陳安龍%孫研%閆振
장국비%오월%왕청%산위%진안룡%손연%염진
经尿道%电切术%浸润性膀胱癌
經尿道%電切術%浸潤性膀胱癌
경뇨도%전절술%침윤성방광암
Transurethral%Ablation%Invasive bladder cancer
目的:探讨短周期多次经尿道深度电切联合膀胱灌注化疗治疗高龄高危T2期浸润性膀胱癌的疗效。方法2011年1月~2013年5月对45例高龄高危T2期浸润性膀胱癌采用2~4次经尿道深度电切联合膀胱灌注化疗,电切间隔时间4~6周,电切深度至脂肪层。结果手术时间15~65 min,平均31 min。6例因肿瘤较大[(3.7±0.4) cm]行短周期4次电切,19例[肿瘤大小(3.2±0.5) cm]行短周期3次电切,20例[肿瘤大小(2.3±0.6) cm]行短周期2次电切。45例随访4~29个月,复发率24.4%(11/45),转移率11.1%(5/45),病死率8.9%(4/45)。结论短周期多次经尿道深度电切联合膀胱灌注化疗治疗高龄高危T2期浸润性膀胱癌疗效确切,方法简单,可重复性强,对于不能耐受或不愿接受根治性膀胱全切的患者,是一种可以谨慎选择的手术治疗方案。
目的:探討短週期多次經尿道深度電切聯閤膀胱灌註化療治療高齡高危T2期浸潤性膀胱癌的療效。方法2011年1月~2013年5月對45例高齡高危T2期浸潤性膀胱癌採用2~4次經尿道深度電切聯閤膀胱灌註化療,電切間隔時間4~6週,電切深度至脂肪層。結果手術時間15~65 min,平均31 min。6例因腫瘤較大[(3.7±0.4) cm]行短週期4次電切,19例[腫瘤大小(3.2±0.5) cm]行短週期3次電切,20例[腫瘤大小(2.3±0.6) cm]行短週期2次電切。45例隨訪4~29箇月,複髮率24.4%(11/45),轉移率11.1%(5/45),病死率8.9%(4/45)。結論短週期多次經尿道深度電切聯閤膀胱灌註化療治療高齡高危T2期浸潤性膀胱癌療效確切,方法簡單,可重複性彊,對于不能耐受或不願接受根治性膀胱全切的患者,是一種可以謹慎選擇的手術治療方案。
목적:탐토단주기다차경뇨도심도전절연합방광관주화료치료고령고위T2기침윤성방광암적료효。방법2011년1월~2013년5월대45례고령고위T2기침윤성방광암채용2~4차경뇨도심도전절연합방광관주화료,전절간격시간4~6주,전절심도지지방층。결과수술시간15~65 min,평균31 min。6례인종류교대[(3.7±0.4) cm]행단주기4차전절,19례[종류대소(3.2±0.5) cm]행단주기3차전절,20례[종류대소(2.3±0.6) cm]행단주기2차전절。45례수방4~29개월,복발솔24.4%(11/45),전이솔11.1%(5/45),병사솔8.9%(4/45)。결론단주기다차경뇨도심도전절연합방광관주화료치료고령고위T2기침윤성방광암료효학절,방법간단,가중복성강,대우불능내수혹불원접수근치성방광전절적환자,시일충가이근신선택적수술치료방안。
Objective-To-probe-into-the-effects-of-multiple-short-cycle-transurethral-deep-ablation-combined-with-intravesical-instillation-chemotherapy-for-high-risk-T2-stage-invasive-bladder-cancer-in-senile-patients-.-Methods-A-total-of-45-senile-patients-with-high-risk-T2-stage-invasive-bladder-cancer-from-January-2011-to-May-2013-were-given-transurethral-deep-ablation-combined-with-chemotherapy-of-intravesical-instillation-every-4--6-weeks,-totally-2--4-times,-until-the-depth-of-ablation-reaching-the-fat-layer-.-Results-The-operation-time-was-15--65-min-(-mean,-31-min).Among-them,-6-patients-with-relatively-large-tumors-(-diameter,-3.7-±0.4-cm)-were-given-short-cycle-transurethral-deep-ablation-for-4-times,-19-patients-(diameter,-3.2-±0.5-cm)-for-3-times,and-20-patients-(diameter,-2.3-±0.6-cm)-for-2-times.All-the-patients-were-followed-up-for-4--29-months.The-postoperative-recurrencerate-was-24.4%-(11/45),-the-metastasis-rate-was-11.1%-(5/45),-and-the-death-rate-was-8.9%-(5/45).-Conclusions-Multiple-short-cycle-transurethral-deep-ablation-combined-with-intravesical-instillation-chemotherapy-for-high--risk-T2-stage-invasive-bladder-cancer-is-effective,-repeatable,-and-easy-to-perform-in-senile-patients,-with-advantages-of-retaining-bladder-functions-and-sexual-functions.It-is-a-proper-alternative-for-patients-who-refuse-or-intolerant-to-radical-cystactomy-.